Opthea share purchase plan
Webprogressive retinal diseases, confirms its share purchase plan (“SPP”) offer opens today. Attached is: a copy of a letter being sent to each Opthea shareholder who, as at 7.00pm … WebAug 15, 2024 · In addition, Opthea has received commitments for US$90M 1 (A$128.57M) via a private institutional equity placement for new shares and launched an A$5M Share …
Opthea share purchase plan
Did you know?
WebBNY Mellon Shareowner Services P. O. Box 505000 Louisville, KY 40233-5000 U.S. Toll Free Telephone: 1-888-BNY-ADRS (1-888-269-2377) Telephone for International Callers: 1-201-680-6825 Website: www.mybnymdr.com E-Mail: [email protected] © 2024 Opthea. All Rights Reserved Privacy Policy Trials Phase 3 wet AMD trial Phase 2b wet … WebAug 15, 2024 · In addition, Opthea has received commitments for US$90M1 (A$128.57M) via a private institutional equity placement for new shares and launched an A$5M Share …
WebAug 14, 2024 · In addition, Opthea has received commitments for US$90M1 (A$128.57M) via a private institutional equity placement for new shares and launched an A$5M Share … WebAug 15, 2024 · Biopharmaceutical company Opthea (OPT) receives binding commitments for a US$90 million (A$127 million) two-tranche placement to institutional investors at …
WebAug 25, 2024 · Opthea Limited (ASX:OPT) is a biopharmaceutical company developing novel therapies to address the unmet need in the treatment of highly... WebFeb 24, 2024 · Key Financial Results. Net loss: US$77.1m (loss widened by 104% from 1H 2024). US$0.17 loss per share (further deteriorated from US$0.11 loss in 1H 2024). earnings-and-revenue-history. All figures ...
WebShares) expected to be issued to participating eligible Opthea shareholders today at an issue price of $1.15 per share, being the same price paid by instit utional investors under the Placement, and a 12.6% discount to the 10-day Volume-Weighted Average Price (“VWAP”) as of 10 August 2024.
WebSep 26, 2024 · January 10, 2024 ordained minister apparelWebMar 24, 2024 · It has underperformed other stocks in the Biotechnology industry by 0.1 percentage points. Opthea stock is currently +0.36% from its 52-week low of $4.19, and -50.59% from its 52-week high of $8.50. There are currently 352.15M shares of OPT outstanding. The market capitalization of OPT is $184.88M. In the past 24 hours, 318 OPT … iran population growth rate macrotrendsWebApr 7, 2024 · Shares of Opthea Limited ( NASDAQ:OPT – Get Rating) shot up 0.6% during trading on Thursday . The company traded as high as $3.84 and last traded at $3.55. 9,587 shares traded hands during... iran physical geographyWebSVB Securities analyst Marc Goodman reiterated a Buy rating on Opthea Limited Sponsored ADR (OPT - Research Report) on October 7 and set a price target of $25.00. The company's shares closed last ... iran plant angriffWebShareholder Meetings Our next AGM Opthea’s Annual General Meeting will take place virtually on Wednesday 16 th November at 9AM AEDT. Previous AGMs AGM 01 Analyst … iran players arrestedWebSep 26, 2024 · Share Pengana has added Opthea to its High Conviction Equities Fund. Pengana's High Conviction Equities Fund limits its investment to an ethically screened portfolio of not more than 20 small to mid-cap companies. iran physical featuresWebAug 14, 2024 · Opthea will also offer eligible Opthea shareholders, being shareholders who had a registered address in Australia or New Zealand on Opthea's register at 7.00pm … iran players anthem